GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (LTS:0QNA) » Definitions » Net Interest Income (for Banks)

Basilea Pharmaceutica (LTS:0QNA) Net Interest Income (for Banks)


View and export this data going back to 2014. Start your Free Trial

What is Basilea Pharmaceutica Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Basilea Pharmaceutica (LTS:0QNA) Business Description

Traded in Other Exchanges
Address
Switzerland Innovation Park, Basel Area, Main Campus, Near Basel, Allschwil, CHE, 4058
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.